Markets:

Overview

News

Currencies

International

Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

52.95 -0.55 (-1.02%)

Streaming Delayed Price Updated: 11:05 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 20, 2024

Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning!

Via InvestorPlace

Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 20, 2024

U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday.

Via Benzinga

Topics Stocks

HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023 ↗

March 19, 2024

HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Harrow Announces Fourth Quarter and Year-End 2023 Financial Results

March 19, 2024

From Harrow, Inc.

Via Business Wire

Harrow: Q4 Earnings Insights ↗

March 19, 2024

Via Benzinga

Earnings Scheduled For March 19, 2024 ↗

March 19, 2024

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Earnings Preview: Harrow Health ↗

March 18, 2024

Via Benzinga

Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024

March 05, 2024

From Harrow, Inc.

Via Business Wire

Recap: Harrow Q3 Earnings ↗

November 13, 2023

Via Benzinga

Harrow Health's Earnings Outlook ↗

November 10, 2023

Via Benzinga

Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products

February 15, 2024

From Harrow, Inc.

Via Business Wire

Harrow Announces New Appointments to its Board of Directors

January 29, 2024

From Harrow, Inc.

Via Business Wire

Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease

January 11, 2024

From Harrow, Inc.

Via Business Wire

Melt Pharmaceuticals Provides Corporate Update

January 03, 2024

From Melt Pharmaceuticals, Inc.

Via Business Wire

Harrow Partners with Leading Healthcare Market Access Technology Platforms

January 03, 2024

From Harrow, Inc.

Via Business Wire

7 Short-Squeeze Stocks That Are Screaming for Speculation ↗

December 24, 2023

If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you.

Via InvestorPlace

Harrow Completes Transfer of the TRIESENCE® New Drug Application

November 29, 2023

From Harrow, Inc.

Via Business Wire

Harrow to Present at Two Investor Conferences in November

November 20, 2023

From Harrow, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 14, 2023

Via Benzinga

Why Is Eyecare-Focused Harrow Health Stock Trading Lower Today? ↗

November 14, 2023

Harrow Health Inc (NASDAQ: HROW) reported Q3 revenues of $34.3 million, an increase of 50% Y/Y, missing the consensus of $37

Via Benzinga

Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 14, 2023

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 14, 2023

Via Benzinga

Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket ↗

November 14, 2023

INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 14, 2023

We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning!

Via InvestorPlace

Beauty Health Reports Downbeat Results, Joins Harrow, Fisker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 14, 2023

U.S. stock futures traded higher this morning on Tuesday, with the Nasdaq futures gaining around 45 points this morning.

Via Benzinga

Home Depot, Beauty Health And 3 Stocks To Watch Heading Into Tuesday ↗

November 14, 2023

With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 13, 2023

Via Benzinga

Harrow Announces Third Quarter 2023 Financial Results

November 13, 2023

From Harrow, Inc.

Via Business Wire

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.